EUVIMEDEUVIMED entdecken
Crossref

Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets

Rebecca M Haley iD, Marshall S Padilla iD, Rakan D El-Mayta, Ryann A Joseph iD, Jesse A Weber, Christian G Figueroa-Espada iD, Alvin J Mukalel, Adele S Ricciardi, Rohan Palanki iD, Hannah C Geisler, Matthew T Jester, Beverly L Davidson und 1 weitere

ACS Nano · 15.04.2025 · 19 (14) · 13790-13804

DOI: 10.1021/acsnano.4c16617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 04.04.2025. Verfasst von Rebecca M Haley und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Ribonucleoproteins, Lung. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsRibonucleoproteinsLungNanoparticlesLipidsCRISPR-Associated Protein 9AnimalsHumansMiceLiposomes

Stichwörter der Autor:innen

DNA barcodingdrug deliveryextrahepaticgene editinghigh-throughput screeninglipid nanoparticleribonucleoprotein

Substanzen

RibonucleoproteinsLipidsCRISPR-Associated Protein 9Lipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
  • Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Rebecca M Haley, Marshall S Padilla, Ryann A Joseph, Christian G Figueroa-Espada, Rohan Palanki, Michael J Mitchell

Förderung

  • NCI NIH HHS
  • NIDCR NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Science Foundation Graduate Research Fellowship Program
  • National Cancer Institute

Zitieren

APA

Haley, R. M., Padilla, M. S., El-Mayta, R. D., Joseph, R. A., Weber, J. A., Figueroa-Espada, C. G., Mukalel, A. J., Ricciardi, A. S., Palanki, R., Geisler, H. C., Jester, M. T., Davidson, B. L., & Mitchell, M. J. (2025). Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets. ACS Nano, 19(14), 13790-13804. https://doi.org/10.1021/acsnano.4c16617

Vancouver

Haley RM, Padilla MS, El-Mayta RD, Joseph RA, Weber JA, Figueroa-Espada CG, et al. Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets. ACS Nano. 2025;19(14):13790-13804. doi:10.1021/acsnano.4c16617

BibTeX
@article{Haley2025,
  author = {Haley, Rebecca M and Padilla, Marshall S and El-Mayta, Rakan D and Joseph, Ryann A and Weber, Jesse A and Figueroa-Espada, Christian G and Mukalel, Alvin J and Ricciardi, Adele S and Palanki, Rohan and Geisler, Hannah C and Jester, Matthew T and Davidson, Beverly L and Mitchell, Michael J},
  title = {Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {14},
  pages = {13790--13804},
  doi = {10.1021/acsnano.4c16617}
}
Kostenlos starten →